$BIVI
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.
Healthcare
Sector
Biotechnology
Industry
Cuong Viet Do
CEO
14
Employees
$2.16
Current Price
$9.50M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 4 | 4 | $49,118.00 | 23,280 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 4 | 4 | $49,118.00 | 23,280 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 4 | 4 | $49,118.00 | 23,280 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 4 | 4 | $49,118.00 | 23,280 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Palumbo Joseph M Chief Medical Officer | Purchase | 4,843 | $2.16 | $10,460.88 | View Details |
| Aug 28, 2026 | Chappell Amy Suzon Director | Purchase | 727 | $2.16 | $1,570.32 | View Details |
| Aug 28, 2026 | KIM JOANNE WENDY Chief Financial Officer | Purchase | 2,500 | $2.18 | $5,450.00 | View Details |
| Aug 27, 2026 | DO CUONG V Director | Purchase | 15,210 | $2.08 | $31,636.80 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: